Glucose subsystem: Hovorka et al25
|
States |
|
Masses of glucose in accessible (plasma) compartment |
|
Masses of glucose in nonaccessible compartment |
Input |
|
Meal disturbance |
Parameters |
Patient mass |
Mass of patient in kg |
|
Non-insulin-dependent glucose flux |
|
Volume of the glucose compartment |
|
The transfer rate constant from the nonaccessible to the accessible compartment |
|
Renal glucose clearance |
|
Endogenous glucose production (EGP) extrapolated to the zero insulin concentration |
|
Amount of glucose given during meal |
|
Availability of glucose |
|
Time for peak glucose absorption |
Insulin kinetic subsystem: Wilinska et al26
|
States |
|
Slow subcutaneous compartment 1 |
|
Fast subcutaneous compartment |
|
Slow subcutaneous compartment 2 |
|
Masses of insulin in accessible (plasma) compartment |
Input |
|
Insulin dosage |
Parameters |
|
Proportion of the total input flux passing through the slower, 2 compartment channel |
|
Rate constant of the slow subcutaneous compartment of insulin |
|
Rate constant of the fast subcutaneous compartment of insulin |
|
Insulin elimination from plasma |
|
Insulin distribution volume |
|
Saturation level describing Michaelis Menten dynamics of insulin degradation for continuous infusion and bolus |
|
The value of insulin mass (mU) at which insulin degradation is equal to half of its maximal value for continuous infusion and bolus |
Insulin dynamic subsystem: Hovorka et al25
|
States |
|
The (remote) effects of insulin on glucose distribution/transport |
|
The (remote) effects of insulin on glucose disposal |
|
The (remote) effects of insulin on EGP |
Parameters |
|
Deactivation rate—insulin action subsystem (glucose distribution/transport) |
|
Deactivation rate—insulin action subsystem (glucose disposal) |
|
Deactivation rate—insulin action subsystem (EGP) |
|
Insulin sensitivity of distribution/transport |
|
Insulin sensitivity of disposal |
|
Insulin sensitivity of EGP |
Pramlintide kinetics subsystem: Clodi et al20
|
States |
|
Pramlintide subcutaneous compartment |
|
Masses of pramlintide in accessible (plasma) compartment |
|
Masses of pramlintide in nonaccessible compartment |
|
Masses of pramlintide in nonaccessible compartment |
|
Represents effective pramlintide compartment responsible for pharmacodynamics effects on glucose |
Input |
|
Pramlintide dosage |
Parameters |
|
Rate constant |
|
Pramlintide elimination from the plasma |
|
Initial distribution volume |
|
Rate constant flux from compartment 2 to 1 |
|
Rate constant flux from compartment 1 to 2 |
|
Rate constant flux from compartment 3 to 3 |
|
Rate constant flux from compartment 2 to 3 |
|
Transport delay of pramlintide from the plasma to the effective compartment |
Pramlintide dynamic subsystem |
States |
|
Time of peak meal absorption at last time point |
|
Time of peak meal absorption at current time point |
|
Gap created when a change in tmax,G occurs |
Parameters |
|
Lag constant on tmax,G
|
|
Time delay on the meal caused by pramlintide |
|
Minimum effective pramlintide concentration |
|
Time at which effective pramlintide concentration changes
|